期刊文献+

原发性肾透明细胞癌中转移相关基因CD99、FKBP5和FLJ13576的表达 被引量:1

Expression of metastasis-associated molecules CD99,FKBP5,FLJ13576 in primary clear cell renal cell carcinoma
原文传递
导出
摘要 目的:探讨肿瘤转移相关分子CD99、FKBP5、FLJ13576在原发性肾透明细胞癌中的表达。方法:应用半定量RT-PCR技术研究肿瘤转移相关分子CD99、FKBP5、FLJ13576在肾透明细胞癌组织和癌旁组织中的差异性表达。结果:CD99、FKBP5、FLJ13576在原发性肾透明细胞癌组织中的表达率分别为72%、60%和48%,而对应癌旁组织中的表达率分别为28%、24%和16%,表达水平也明显不同。肾透明细胞癌组织中CD99、FKBP5和FLJ13576 3种基因的表达水平均显著高于癌周组织(P<0.05)。结论:肿瘤转移相关分子CD99、FKBP5、FLJ13576在肾透明细胞癌原发组织中的表达明显上调,可能与肾细胞癌发生、发展密切相关,有望成为检测肾细胞癌的新的生物学标志。 Objective: To evaluate the expression of metastasis associated molecules CD99, FKBP5 and FLJ13576 in primary clear cell renal cell carcinoma (ccRCC). Methods: Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to examine the differential expression of CD99, FKBP5, and FLJ13576 in the primary ccRCC tissues and the corresponding adjacent normal renal tissues. Results: The positive rates of CD99, FKBPS, and FLJ13576 in the primary ccRCC tissues were 72%, 60% and 48%, respectively, which were significantly higher than those in the adjacent normal renal tissues(28%, 24%, and 16%, P〈0.05). Conclusion: Cancer metastasis-associated molecules CD99, FKBP5 and FLJ13576 are highly expressed in the primary ccRCC tissues, which might be associated with the development and progression of renal cancer. CD99, FKBP5 and FLJ13576 may serve as potential markers for detection of ccRCC.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2009年第4期360-363,共4页 Academic Journal of Second Military Medical University
基金 上海市教委科技创新重点项目(08zz39)~~
关键词 肾肿瘤 CD99 FKBP5 FLJ13576 基因表达 透明细胞癌 kidney neoplasms CD99 FKBP5 FLJ13576 gene expression clear cell carcinoma
  • 相关文献

参考文献15

  • 1Liou L S, Shi T, Duan Z H, Sadhukhan P, Der S D, Novick A A, et al. Microarray gene expression profiling and analysis in renal cell carcinoma[J]. BMC Urol, 2004,4 : 9.
  • 2Garcia J A, Rini B L Recent progress in the management of advanced renal cell carcinoma[J]. CA Cancer J Clin,2007,57: 112-125.
  • 3Tan X, Zhai Y, Chang W, Hou J, He S, Lin L, et al. Global analysis of metastasis associated gene expression in primary cultures from clinical specimens of clear-cell renal cell carcinoma[J]. Int J Cancer,2008,123 : 1080-1088.
  • 4Kim S H, Shin Y K, Lee I S, Bae Y M, Sohn H W, Suh Y H, et al. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype[J]. Blood, 2000, 95 : 294-300.
  • 5Kim S H,Choi E Y,Shin Y K,Kim T J,Chung D H,Chang S I, et al. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2)[J]. Blood, 1998,92 : 4287-4295.
  • 6Granter S R, Renshaw A A, Fletcher C D, Bhan A K, Rosenberg A E. CD99 reactivity in mesenchymal chondrosarcoma[J]. HumPathol,1996,27:1273-1276.
  • 7Choi Y L, Chi J G, Suh Y L. CD99 immunoreactivity in ependymoma[J]. Appl Immunohistochem Mol Morphol, 2001, 9:125-129.
  • 8Scotlandi K, Perdichizzi S, Bernard G, Nicoletti G, Nanni P, Lollini P L,et al. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma[J]. Eur J Cancer,2006,42:91-96.
  • 9郭东辉,范敬东,师宜荃,王萍.CD99在卵巢性索-间质肿瘤中的表达[J].中华病理学杂志,2002,31(3):257-258. 被引量:9
  • 10Jiang W, Cazacu S, Xiang C, Zenklusen J C, Fine H A, Berens M, et al. FKS06 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway[J]. Neoplasia,2008,10:235-243.

二级参考文献1

共引文献8

同被引文献16

  • 1Cohen H T,McGovern F J. Renal cell careinoma[J]. N Engl J Med,2005,353:2477- 2490.
  • 2Garcia J A,Rini B I. Recent progress in the management of ad- vanced renal cell carcinoma[J]. CA Cancer J Clin, 2007,57 : 112- 125.
  • 3Liou L S,Shi T,Duan Z H,Sadb.ukhan P,Der S D,Novick A A, et al. Microarray gene expression profiling and analysis in renal cell carcinoma[J]. BMC Urol, 2004,4 : 9.
  • 4Kim S P,AIt A L,Weight C J,Costello B A,Cheville J C,Lohse C,et al. Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carci noma: Results From a Large, Single Institution Cohort [J]. J Urol,2011. [ Epub ahead of print].
  • 5Kiatte T,Patard J J,de Martino M,Bensalah K,Verhoest G,de la Taille A,et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas[J]. J Urol, 2008,179:1719 -1726.
  • 6Lee J H,Kim S H,Wang L H,Choi Y L,Kim Y C,Kim J H,et al. Clinical significance of CD99 down regulation in gastric ade -nocarcinoma[J]. Clin Cancer Res, 2007,13 : 2584- 2591.
  • 7Bernard G, Zoccola D, Deckert M, Breittmayer J P, Aussel C Bernard A. The E2 molecule (CD99) specifically triggers homo- typic aggregation of CD4^+ CD8^+ thymoeytes. [J]. J Immunol 1995,154:26- 32.
  • 8Kim S H,Choi E Y,Shin Y K,Kim T J,Chung D H,Chang S I, et al. Generation of cells with Hodgkin's and Reed- Sternberg phenotype through downregulation of CD99 (Mic2)[J]. Blood, 1998,92:4287-4295.
  • 9Bernard G, Breittmayer J P, de Matteis M, Trampont P, Hof- man P,Senik A,et al. Apoptosis of immature thymoeytes medi- ated by E2/CD99[J]. J Immunol, 1997,158:2543- 2550.
  • 10Tan X, Zhai Y, Chang W, Hou J, He S, Lin L, et al. Global anal- ysis of metastasis associated gene expression in primary cul- tures from clinical specimens of clear-cell renal-cell carcinoma [J]. Int J Cancer,2008,123:1080- 1088.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部